Melanoma antigen preferentially expressed in tumors (142-151)
  1. Home
  2. Peptide
  3. Others
  4. Melanoma antigen preferentially expressed in tumors (142-151)
Need Assistance?
  • US & Canada:
    +
  • UK: +

Melanoma antigen preferentially expressed in tumors (142-151)

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Melanoma antigen preferentially expressed in tumors (142-151) is a bioactive peptide of Melanoma antigen preferentially expressed in tumors. Melanoma antigen preferentially expressed in tumors inhibits the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG as a transcriptional repressor.

Category
Others
Catalog number
BAT-009678
Synonyms
Opa-interacting protein 4 (142-151); Preferentially expressed antigen of melanoma (142-151)
Sequence
SLYSFPEPEA
Storage
Common storage 2-8°C, long time storage -20°C.
Related Products
6-Chloro-3-methylpicolinaldehyde
6-Chloro-3-methylpicolinaldehyde

CAT NO. : BAT-008314
FOXO4-DRI
FOXO4-DRI

CAT NO. : BAT-006150
Epobis
Epobis

CAT NO. : BAT-006257
Calcineurin substrate
Calcineurin substrate

CAT NO. : BAT-006181
Semaxinib
Semaxinib

CAT NO. : BAT-008962
Hexapeptide-3
Hexapeptide-3

CAT NO. : BAT-006157
Online Inquiry
Verification code
Inquiry Basket
Loading ......
Delete selectedGo to checkout